NeuroVive's NeuroSTAT Project Receives FDA Fast Track Designation
LUND, Sweden, July 28, 2019 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (OTCQX: NEVPF) today announced that the company's candidate drug NeuroSTAT, in development for treatment of moderate to severe traumatic brain injury, TBI, has received Fast Track designation from the ...
2019-07-28 21:47
6071